Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease

Journal of the American College of Cardiology

Volumn 34, Issue 7, 1999, Pages 1995-2001

  Porsch Oezçueruemez, Mustafa ^a   Kunz, Dagmar ^b,c   Kloer, Hans Ulrich ^b   Luley, Claus ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE RECEPTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE RELEASE; DISEASE MARKER; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

ADULT; AGED; ANTIGENS, CD; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RISK FACTORS; ROC CURVE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0343067111     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00473-8     Document Type: Article

References (29)

1. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
2. Morisaki N., Saito I., Tamura K., et al. New indices of ischemic heart disease and aging studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease . Atherosclerosis. 131:1997;43-48.
3. Zeitler H., Ko Y., Zimmermann C., et al. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. Eur J Med Res. 2:1997;389-394.
4. Peter K., Nawroth P., Conradt C., et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol. 17:1997;505-512.
5. Braun M., Pietsch P., Felix S.B., et al. Modulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 on human coronary smooth muscle cells by cytokines. J Mol Cell Cardiol. 27:1995;2571-2579.
6. Erbel R., Sommerfeld U., Ashry M., et al. [Quality management in the heart catheterization laboratory]. Z Kardiol. 83:(Suppl 6):1994;43-55.
7. Gleichmann U., Mannebach H., Lichtlen P. [13th Report on the structure and performance statistics of heart catheterization laboratories in Germany]. Z Kardiol. 86:1997;879-881.
8. National Institutes of Health. Manual of Laboratory Operations. Vol. 1. Washington, DC: Lipid Research Clinics Program, DHEW, NIH publication no. 75-628, 1974.
9. Beck J.R., Shultz E.K. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med. 110:1986;13-20.
10. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots a fundamental evaluation tool in clinical medicine . Clin Chem. 39:1993;561-577.
11. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. 1988;Lawrence Erlbaum Assoc, New York.
12. Gillum R.F., Ingram D.D., Makuc D.M. White blood cell count, coronary heart disease, and death the NHANES I epidemiologic follow-up study . Am Heart J. 125:1993;855-863.
13. Heinrich J., Schulte H., Schonfeld R., et al. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 73:1995;374-379.
14. Ridker P.M., Cushman M., Stampfer M.J. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
15. Ledue T.B., Weiner D.L., Sipe J.D., et al. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem. 35:1998;745-753.
16. Fukuo Y., Nagashima M., Soya-Ohmura N., et al. Effects of an HMG-CoA reductase inhibitor on cytokine production by human monocytes/macrophages. Nippon Ika Daigaku Zasshi. 62:1995;386-390.
17. Giroux L.M., Davignon J., Naruszewicz M. Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages. Biochim Biophys Acta. 1165:1993;335-338.
18. Tartaglia L.A., Goeddel D.V. Two TNF receptors. Immunol Today. 13:1992;151-153.
19. Tartaglia L.A., Pennica D., Goeddel D.V. Ligand passing the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor . J Biol Chem. 268:1993;18542-18548.
20. Douvdevani A., Einbinder T., Yulzari R., et al. TNF-receptors on human peritoneal mesothelial cells regulation of receptor levels and shedding by IL-1 alpha and TNF alpha . Kidney Int. 50:1996;219-228.
21. Gown A.M., Tsukada T., Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 125:1986;191-207.
22. Beutler B.A., Milsark I.W., Cerami A. Cachectin/tumor necrosis factor production, distribution, and metabolic fate in vivo . J Immunol. 135:1985;3972-3977.
23. Corti A., Poiesi C., Merli S., et al. Tumor necrosis factor (TNF) alpha quantification by ELISA and bioassay effects of TNF alpha-soluble TNF receptor (p55) complex dissociation during assay incubations . J Immunol Methods. 177:1994;191-198.
24. Deng M.C., Erren M., Kammerling L., et al. The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation. 60:1995;1118-1124.
25. Diamantstein T., Osawa H., Mouzaki A., et al. Regulation of interleukin-2 receptor expression and receptor release. Mol Immunol. 23:1986;1165-1172.
26. Kishikawa H., Shimokama T., Watanabe T. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima role of cell-mediated immunity in human atherogenesis . Virchows Arch A Pathol Anat Histopathol. 423:1993;433-442.
27. Munger M.A., Johnson B., Amber I.J., et al. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 77:1996;723-727.
28. Kapadia S., Dibbs Z., Kurrelmeyer K. The role of cytokines in the failing human heart. Cardiol Clin. 16:1998;645-656.
29. Frenette P.S., Wagner D.D. Insights into selectin function from knockout mice. Thromb Haemost. 78:1997;60-64.